175 related articles for article (PubMed ID: 19635560)
21. Differential response of regulatory and conventional CD4⁺ lymphocytes to CD3 engagement: clues to a possible mechanism of anti-CD3 action?
Li L; Nishio J; van Maurik A; Mathis D; Benoist C
J Immunol; 2013 Oct; 191(7):3694-704. PubMed ID: 23986534
[TBL] [Abstract][Full Text] [Related]
22. Inhibins regulate peripheral regulatory T cell induction through modulation of dendritic cell function.
de la Fuente-Granada M; Olguín-Alor R; Ortega-Francisco S; Bonifaz LC; Soldevila G
FEBS Open Bio; 2019 Jan; 9(1):137-147. PubMed ID: 30652081
[TBL] [Abstract][Full Text] [Related]
23. Adaptive plasticity of natural interleukin-35-induced regulatory T cells (Tr35) that are required for T-cell immune regulation.
Wei X; Zhang J; Cui J; Xu W; Zhao G; Guo C; Yuan W; Zhou X; Ma J
Theranostics; 2024; 14(7):2897-2914. PubMed ID: 38773985
[No Abstract] [Full Text] [Related]
24. Ethanol inhibits antigen presentation by dendritic cells.
Eken A; Ortiz V; Wands JR
Clin Vaccine Immunol; 2011 Jul; 18(7):1157-66. PubMed ID: 21562114
[TBL] [Abstract][Full Text] [Related]
25. CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens.
Yu XZ; Albert MH; Martin PJ; Anasetti C
J Clin Invest; 2004 Jun; 113(11):1624-30. PubMed ID: 15173889
[TBL] [Abstract][Full Text] [Related]
26. Polyclonally Derived Alloantigen-Specific T Regulatory Cells Exhibit Target-Specific Suppression and Capture MHC Class II from Dendritic Cells.
Oya Y; Tanaka Y; Nakazawa T; Matsumura R; Glass DD; Nakajima H; Shevach EM
J Immunol; 2024 Jun; 212(12):1891-1903. PubMed ID: 38683146
[TBL] [Abstract][Full Text] [Related]
27. Oral alloantigen exposure promotes donor-specific tolerance in a mouse model of minor-mismatched skin transplantation.
Wang P; Chen L; McIntosh CM; Lane JI; Li R; Xie SZ; Sattar H; Esterhazy D; Chong AS; Alegre ML
Am J Transplant; 2022 Oct; 22(10):2348-2359. PubMed ID: 35633180
[TBL] [Abstract][Full Text] [Related]
28. Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials.
Berglund D; Karlsson M; Biglarnia AR; Lorant T; Tufveson G; Korsgren O; Carlsson B
Clin Exp Immunol; 2013 Aug; 173(2):310-22. PubMed ID: 23607776
[TBL] [Abstract][Full Text] [Related]
29. Intragraft memory-like CD127hiCD4+Foxp3+ Tregs maintain transplant tolerance.
Zhao Y; Nicholson L; Wang H; Qian YW; Hawthorne WJ; Jimenez-Vera E; Gloss BS; Lai J; Thomas A; Chew YV; Burns H; Zhang GY; Wang YM; Rogers NM; Zheng G; Yi S; Alexander SI; O'Connell PJ; Hu M
JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38516885
[TBL] [Abstract][Full Text] [Related]
30. Control of homeostatic proliferation by regulatory T cells.
Shen S; Ding Y; Tadokoro CE; Olivares-Villagómez D; Camps-Ramírez M; Curotto de Lafaille MA; Lafaille JJ
J Clin Invest; 2005 Dec; 115(12):3517-26. PubMed ID: 16294223
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice.
Wilhelm AJ; Zabalawi M; Owen JS; Shah D; Grayson JM; Major AS; Bhat S; Gibbs DP; Thomas MJ; Sorci-Thomas MG
J Biol Chem; 2010 Nov; 285(46):36158-69. PubMed ID: 20833724
[TBL] [Abstract][Full Text] [Related]
32. Effects of tumor irradiation on host T-regulatory cells and systemic immunity in the context of adoptive T-cell therapy in mice.
Wei S; Egenti MU; Teitz-Tennenbaum S; Zou W; Chang AE
J Immunother; 2013 Feb; 36(2):124-32. PubMed ID: 23377667
[TBL] [Abstract][Full Text] [Related]
33. Skin-derived TSLP systemically expands regulatory T cells.
Leichner TM; Satake A; Harrison VS; Tanaka Y; Archambault AS; Kim BS; Siracusa MC; Leonard WJ; Naji A; Wu GF; Artis D; Kambayashi T
J Autoimmun; 2017 May; 79():39-52. PubMed ID: 28126203
[TBL] [Abstract][Full Text] [Related]
34. Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation.
Mirmonsef P; Tan G; Zhou G; Morino T; Noonan K; Borrello I; Levitsky HI
Blood; 2008 Feb; 111(4):2112-21. PubMed ID: 18063750
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside.
Chae WJ; Bothwell ALM
Front Immunol; 2018; 9():303. PubMed ID: 29503652
[TBL] [Abstract][Full Text] [Related]
36. Infectious tolerance via the consumption of essential amino acids and mTOR signaling.
Cobbold SP; Adams E; Farquhar CA; Nolan KF; Howie D; Lui KO; Fairchild PJ; Mellor AL; Ron D; Waldmann H
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12055-60. PubMed ID: 19567830
[TBL] [Abstract][Full Text] [Related]
37. Pathogen-sensing and regulatory T cells: integrated regulators of immune responses.
Paul WE; Grossman Z
Cancer Immunol Res; 2014 Jun; 2(6):503-9. PubMed ID: 24894087
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic potential of FOXP3(+) regulatory T cells and their interactions with dendritic cells.
Tran DQ; Shevach EM
Hum Immunol; 2009 May; 70(5):294-9. PubMed ID: 19236900
[TBL] [Abstract][Full Text] [Related]
39. CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells.
Arroyo Hornero R; Georgiadis C; Hua P; Trzupek D; He LZ; Qasim W; Todd JA; Ferreira RC; Wood KJ; Issa F; Hester J
Commun Biol; 2020 Jul; 3(1):375. PubMed ID: 32665635
[TBL] [Abstract][Full Text] [Related]
40. CD4+ regulatory T cells in solid organ transplantation.
Issa F; Wood KJ
Curr Opin Organ Transplant; 2010 Dec; 15(6):757-64. PubMed ID: 20881492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
